Diane Bandon-Tourret, partner and head of the life sciences practice at LexCase, and Tamara Milano, associate in the life sciences practice, consider new regulations in France aimed towards avoiding shortages of medical products
These last years, shortages became a major public health concern, highlighted by the Covid-19 crisis and the current shortages of major medicines. As a result, adoption of new regulations to prevent shortages have become a priority for many countries. In the EU, new regulations have strengthened shortages prevention, such as Regulation (EU) 2023/607 which extended the validity period of CE certificates issued under the previous regulation to avoid the unavailability of medical devices (MDs). In France, regulations on shortages recently evolved in the field of medicines, MDs and in vitro diagnostic devices (IVDs).
Your limit of 1 article in 30 days is up. Please login for full access or subscribe.
Corporate users - click here for simple access (no password needed).
For more information, please contact jasmine.glass@legalbusiness.co.uk
